Oncogene - Table of Contents alert Volume 35 Issue 46

If you are unable to see the message below, click here to view.

Advertisement RNA-sequencing from just 10pg. New CATS RNA-seq library preparation from Diagenode. Ligation-free assay - increased efficiency and minimum bias Libraries ready to sequence in only 5 hours Low inputs down to 10 pictograms Learn more. TABLE OF CONTENTS Volume 35, Issue 46 (November 2016) In this issue Review Original Articles Short Communication Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Open for Submissions  npj Precision Oncology is a new open access, online-only, peer-reviewed journal committed to publishing cutting-edge scientific research in all aspects of precision oncology from basic science to translational applications, to clinical medicine. The journal is part of the Nature Partner Journals series and published in partnership with The Hormel Institute, University of Minnesota.  Explore the benefits of submitting your manuscript >>> Review Top Damage-associated molecular patterns in cancer: a double-edged sword C Hernandez, P Huebener and R F Schwabe Oncogene 2016 35: 5931-5941; advance online publication, April 18, 2016; 10.1038/onc.2016.104 Abstract | Full Text Original Articles Top SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival F Schmid, Q Wang, M R Huska, M A Andrade-Navarro, M Lemm, I Fichtner, M Dahlmann, D Kobelt, W Walther, J Smith, P M Schlag and U Stein Oncogene 2016 35: 5942-5952; advance online publication, December 21, 2015; 10.1038/onc.2015.451 Abstract | Full Text Type I interferons exert anti-tumor effect via reversing immunosuppression mediated by mesenchymal stromal cells OPEN P Shou, Q Chen, J Jiang, C Xu, J Zhang, C Zheng, M Jiang, T Velletri, W Cao, Y Huang, Q Yang, X Han, L Zhang, L Wei, A B Rabson, Y E Chin, Y Wang and Y Shi Oncogene 2016 35: 5953-5962; advance online publication, April 25, 2016; 10.1038/onc.2016.128 Abstract | Full Text Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties OPEN A N Paranjape, R Soundararajan, S J Werden, R Joseph, J H Taube, H Liu, J Rodriguez-Canales, N Sphyris, I Wistuba, N Miura, J Dhillon, N Mahajan, K Mahajan, J T Chang, M Ittmann, S N Maity, C Logothetis, D G Tang and S A Mani Oncogene 2016 35: 5963-5976; advance online publication, January 25, 2016; 10.1038/onc.2015.498 Abstract | Full Text Phosphorylation of serine 367 of FOXC2 by p38 regulates ZEB1 and breast cancer metastasis, without impacting primary tumor growth OPEN S J Werden, N Sphyris, T R Sarkar, A N Paranjape, A M LaBaff, J H Taube, B G Hollier, E Q Ramirez-Peña, R Soundararajan, P den Hollander, E Powell, G V Echeverria, N Miura, J T Chang, H Piwnica-Worms, J M Rosen and S A Mani Oncogene 2016 35: 5977-5988; advance online publication, June 13, 2016; 10.1038/onc.2016.203 Abstract | Full Text FOXO1 is a TXN- and p300-dependent sensor and effector of oxidative stress in diffuse large B-cell lymphomas characterized by increased oxidative metabolism T Sewastianik, M Szydlowski, E Jablonska, E Bialopiotrowicz, P Kiliszek, P Gorniak, A Polak, M Prochorec-Sobieszek, A Szumera-Cieckiewicz, T S Kaminski, S Markowicz, E Nowak, M A Grygorowicz, K Warzocha and P Juszczynski Oncogene 2016 35: 5989-6000; advance online publication, May 2, 2016; 10.1038/onc.2016.126 Abstract | Full Text microRNA-23a, -27a and -24 synergistically regulate JAK1/Stat3 cascade and serve as novel therapeutic targets in human acute erythroid leukemia R Su, L Dong, D Zou, H Zhao, Y Ren, F Li, P Yi, L Li, Y Zhu, Y Ma, J Wang, F Wang and J Yu Oncogene 2016 35: 6001-6014; advance online publication, April 18, 2016; 10.1038/onc.2016.127 Abstract | Full Text miR-155 downregulates ErbB2 and suppresses ErbB2-induced malignant transformation of breast epithelial cells X-H He, W Zhu, P Yuan, S Jiang, D Li, H-W Zhang and M-F Liu Oncogene 2016 35: 6015-6025; advance online publication, April 11, 2016; 10.1038/onc.2016.132 Abstract | Full Text A multidimensional network approach reveals microRNAs as determinants of the mesenchymal colorectal cancer subtype OPEN E Fessler, M Jansen, F De Sousa E Melo, L Zhao, P R Prasetyanti, H Rodermond, R Kandimalla, J F Linnekamp, M Franitza, S R van Hooff, J H de Jong, S C Oppeneer, C J M van Noesel, E Dekker, G Stassi, X Wang, J P Medema and L Vermeulen Oncogene 2016 35: 6026-6037; advance online publication, May 9, 2016; 10.1038/onc.2016.134 Abstract | Full Text Short Communication Top Tumour cell-derived exosomes endow mesenchymal stromal cells with tumour-promotion capabilities OPEN L Y Lin, L M Du, K Cao, Y Huang, P F Yu, L Y Zhang, F Y Li, Y Wang and Y F Shi Oncogene 2016 35: 6038-6042; advance online publication, May 2, 2016; 10.1038/onc.2016.131 Abstract | Full Text Corrigendum Top STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer OPEN Z Zhang, X Liu, B Feng, N Liu, Q Wu, Y Han, Y Nie, K Wu, Y Shi and D Fan Oncogene 2016 35: 6043; advance online publication, July 4, 2016; 10.1038/onc.2016.140 Full Text Repression of microRNA-768-3p by MEK/ERK signalling contributes to enhanced mRNA translation in human melanoma C C Jiang, A Croft, H-Y Tseng, S T Guo, L Jin, P Hersey and X D Zhang Oncogene 2016 35: 6044; advance online publication, June 27, 2016; 10.1038/onc.2016.144 Full Text Advertisement Brought to you by the American College of Gastroenterology, Clinical and Translational Gastroenterology is an online-only, open access journal in the field of clinical and translational gastroenterological diseases, seeking to promote timely medical research in gastroenterology and hepatology. Explore the benefits of submitting your next research article. Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.